Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$942M |
| 2 |
Microsoft
MSFT
|
+$776M |
| 3 |
Bank of America
BAC
|
+$558M |
| 4 |
Apple
AAPL
|
+$484M |
| 5 |
NVIDIA
NVDA
|
+$400M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
Materials Select Sector SPDR Fund
XLB
|
+$1.07B |
| 3 |
The Communication Services Select Sector SPDR Fund
XLC
|
+$942M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$904M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$785M |
Sector Composition
| 1 | Technology | 28.65% |
| 2 | Financials | 12.34% |
| 3 | Healthcare | 11.76% |
| 4 | Consumer Discretionary | 10.56% |
| 5 | Communication Services | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Marqeta
MQ
$2.61B
| $1.64M | ﹤0.01% |
273,726
-25,780
| -9% | -$154K |
|
1727
Winnebago Industries
WGO
$949M
| $1.64M | ﹤0.01% |
27,558
+6
| +0% | +$357 |
|
1728
Ascendis Pharma
ASND
$11.8B
| $1.64M | ﹤0.01% |
17,482
+16,874
| +2,775% | +$1.58M |
|
1729
Elastic
ESTC
$9.3B
| $1.64M | ﹤0.01% |
20,153
+904
| +5% | +$73.4K |
|
1730
O-I Glass
OI
$1.99B
| $1.63M | ﹤0.01% |
97,262
+6,649
| +7% | +$111K |
|
|
INST
1731
DELISTED
Instructure Holdings, Inc.
INST
| $1.62M | ﹤0.01% |
63,956
+17,873
| +39% | +$454K |
|
1732
Carpenter Technology
CRS
$12B
| $1.62M | ﹤0.01% |
24,148
-1,098
| -4% | -$73.8K |
|
1733
Independent Bank Corp
IBCP
$657M
| $1.62M | ﹤0.01% |
88,307
-4,700
| -5% | -$86.2K |
|
1734
Day One Biopharmaceuticals
DAWN
$729M
| $1.62M | ﹤0.01% |
131,882
-12,521
| -9% | -$154K |
|
1735
EPR Properties
EPR
$4.45B
| $1.62M | ﹤0.01% |
39,010
-10,742
| -22% | -$446K |
|
|
PDCO
1736
DELISTED
Patterson Companies, Inc.
PDCO
| $1.62M | ﹤0.01% |
54,513
-10,707
| -16% | -$317K |
|
1737
Novo Nordisk
NVO
$244B
| $1.61M | ﹤0.01% |
17,694
-9,842
| -36% | -$895K |
|
1738
Washington Trust Bancorp
WASH
$573M
| $1.61M | ﹤0.01% |
61,091
-1,869
| -3% | -$49.2K |
|
1739
Triple Flag Precious Metals
TFPM
$5.92B
| $1.61M | ﹤0.01% |
123,003
+907
| +0.7% | +$11.9K |
|
1740
Biomea Fusion
BMEA
$115M
| $1.61M | ﹤0.01% |
116,621
+49,485
| +74% | +$681K |
|
1741
Aclaris Therapeutics
ACRS
$211M
| $1.6M | ﹤0.01% |
234,150
+148,761
| +174% | +$1.02M |
|
1742
Privia Health
PRVA
$2.8B
| $1.6M | ﹤0.01% |
69,545
+13,656
| +24% | +$314K |
|
1743
Banco Bradesco
BBD
$33.1B
| $1.6M | ﹤0.01% |
560,318
-204,232
| -27% | -$582K |
|
1744
Green Brick Partners
GRBK
$3.21B
| $1.6M | ﹤0.01% |
38,430
-15,235
| -28% | -$632K |
|
1745
HSBC
HSBC
$238B
| $1.59M | ﹤0.01% |
40,271
+64
| +0.2% | +$2.53K |
|
1746
Ameresco
AMRC
$1.44B
| $1.58M | ﹤0.01% |
41,068
+28,832
| +236% | +$1.11M |
|
1747
A10 Networks
ATEN
$1.26B
| $1.58M | ﹤0.01% |
105,462
-4,376
| -4% | -$65.7K |
|
1748
Integra LifeSciences
IART
$1.17B
| $1.58M | ﹤0.01% |
41,478
-13,370
| -24% | -$510K |
|
1749
Community Trust Bancorp
CTBI
$1.03B
| $1.58M | ﹤0.01% |
46,134
+3,176
| +7% | +$109K |
|
1750
Keros Therapeutics
KROS
$636M
| $1.58M | ﹤0.01% |
49,511
+11,118
| +29% | +$354K |
|